| 000 | 01545 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516050129.0 | ||
| 264 | 0 | _c20121128 | |
| 008 | 201211s 0 0 eng d | ||
| 022 | _a1879-0461 | ||
| 024 | 7 |
_a10.1016/j.critrevonc.2011.06.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMaresch, Judith | |
| 245 | 0 | 0 |
_aHer-2/neu gene amplification and over-expression in stomach and esophageal adenocarcinoma: from pathology to treatment. _h[electronic resource] |
| 260 |
_bCritical reviews in oncology/hematology _cJun 2012 |
||
| 300 |
_a310-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Review | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aEsophageal Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aGene Amplification _xdrug effects |
| 650 | 0 | 4 |
_aGene Expression _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aStomach Neoplasms _xdrug therapy |
| 700 | 1 | _aSchoppmann, Sebastian F | |
| 700 | 1 | _aThallinger, Christiane M R | |
| 700 | 1 | _aZielinski, Christoph C | |
| 700 | 1 | _aHejna, Michael | |
| 773 | 0 |
_tCritical reviews in oncology/hematology _gvol. 82 _gno. 3 _gp. 310-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.critrevonc.2011.06.003 _zAvailable from publisher's website |
| 999 |
_c21030163 _d21030163 |
||